FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan

      Boston Scientific Expands Portfolio with FDA Clearance and Investment in Galway

      Boston Scientific has achieved FDA 510(k) clearance for its Asurys Fluid Management System, enhancing its StoneSmart portfolio aimed at urologic procedures. This development is part of the company's strategy to expand its offerings in minimally invasive therapies.

      In addition to the FDA clearance, Boston Scientific has announced a €75 million investment to expand its cardiovascular research and development facilities in Galway, Ireland. This investment is supported by IDA Ireland and underscores the company's commitment to innovation in a significant global medtech hub.

      These initiatives reflect Boston Scientific's dual approach of broadening its product range while reinforcing its research capabilities, positioning the company for future growth in the medical technology sector.

      © 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

      Source: KLEA News

      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud